BBV152 (קובקסין) (Hebrew Wikipedia)

Analysis of information sources in references of the Wikipedia article "BBV152 (קובקסין)" in Hebrew language version.

refsWebsite

Global rank Hebrew rank

4indianexpress.com

60^th place

1,124^th place

3doi.org

2^nd place

10^th place

3thehindu.com

52^nd place

1,474^th place

2livemint.com

390^th place

4,661^st place

2hindustantimes.com

71^st place

1,343^rd place

1theprint.in

987^th place

low place

1nytimes.com

7^th place

32^nd place

1ddnews.gov.in

low place

1washingtonpost.com

34^th place

94^th place

1medrxiv.org

low place

8,738^th place

1clinicaltrials.gov

5,225^th place

3,089^th place

1nih.gov

4^th place

18^th place

1businesstoday.in

1,332^nd place

low place

1newindianexpress.com

188^th place

6,396^th place

1reuters.com

49^th place

105^th place

1indiatimes.com

17^th place

513^th place

1calcalist.co.il

2,363^rd place

16^th place

1rotter.net

low place

425^th place

1bbc.com

20^th place

65^th place

bbc.com

"Coronavirus: India approves vaccines from Bharat Biotech and Oxford/AstraZeneca". BBC News (באנגלית בריטית). 2021-01-03. נבדק ב-2021-01-03.

businesstoday.in

"Coronavirus vaccine update: Bharat Biotech's Covaxin launch likely in Q2 of 2021, no word on pricing yet". www.businesstoday.in. India Today Group. נבדק ב-13 בדצמבר 2020. {{cite news}}: (עזרה)

calcalist.co.il

היעד של ביידן: 100 מיליון חיסונים ב-100 ימים, באתר כלכליסט, 8 בדצמבר 2020

clinicaltrials.gov

"An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers". clinicaltrials.gov (Registry). United States National Library of Medicine. NCT04641481. נבדק ב-2020-11-26.

ddnews.gov.in

"Human clinical trials of potential Covid-19 vaccine 'COVAXIN' started at AIIMS". DD News. Prasar Bharati, Ministry of I & B, Government of India. 25 ביולי 2020. {{cite news}}: (עזרה)

doi.org

Ella, Raches; Mohan, Krishna; Jogdand, Harsh; Prasad, Sai; Reddy, Siddharth; Sarangi, Vamshi Krishna; Ganneru, Brunda; Sapkal, Gajanan; Yadav, Pragya (15 בדצמבר 2020). "Safety and immunogenicity trial of an inactivated SARS-CoV-2 vaccine-BBV152: a phase 1, double-blind, randomised control trial". medRxiv (באנגלית). doi:10.1101/2020.12.11.20210419. {{cite web}}: (עזרה)
"Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion InactivatedSARS-CoV-2 Vaccine - BBV152". 9 בספטמבר 2020. doi:10.1101/2020.09.09.285445. {{cite journal}}: (עזרה); Cite journal requires |journal= (עזרה)
"Enhancing viral vaccine production using engineered knockout vero cell lines - A second look". Vaccine. 36 (16): 2093–2103. באפריל 2018. doi:10.1016/j.vaccine.2018.03.010. PMID 29555218free {{cite journal}}: (עזרה)תחזוקה - ציטוט: postscript (link)

hindustantimes.com

Sabarwal, Harshit (16 בדצמבר 2020). "Covaxin's phase 1 trial result shows robust immune response, mild adverse events". Hindustan Times (באנגלית). נבדק ב-17 בדצמבר 2020. {{cite news}}: (עזרה)
"Bharat Biotech seeks emergency use authorization for Covid-19 vaccine". Hindustan Times (באנגלית). 7 בדצמבר 2020. {{cite news}}: (עזרה)

indianexpress.com

"Delhi: 30-year-old is first to get dose of trial drug Covaxin". The Indian Express (באנגלית). 25 ביולי 2020. {{cite news}}: (עזרה)
"Bharat Biotech begins Covaxin Phase III trials". The Indian Express (באנגלית). 18 בנובמבר 2020. {{cite news}}: (עזרה)
"Bharat Biotech exploring global tie-ups for Covaxin manufacturing". The Indian Express (באנגלית). 24 בספטמבר 2020. {{cite news}}: (עזרה)
"Expert panel recommends granting approval for restricted emergency use of Bharat Biotech's Covaxin". The Indian Express (באנגלית). 2 בינואר 2021. {{cite news}}: (עזרה)

indiatimes.com

economictimes.indiatimes.com

"Bharat Biotech, Ocugen to co-develop Covaxin for US market". The Economic Times. נבדק ב-2021-01-05.

livemint.com

"ICMR teams up with Bharat Biotech to develop Covid-19 vaccine". Livemint (באנגלית). 9 במאי 2020. {{cite news}}: (עזרה)
"List of states that have started phase 3 trials of India's first Covid vaccine". mint (באנגלית). 2 בדצמבר 2020. {{cite news}}: (עזרה)

medrxiv.org

Ella, Raches; Mohan, Krishna; Jogdand, Harsh; Prasad, Sai; Reddy, Siddharth; Sarangi, Vamshi Krishna; Ganneru, Brunda; Sapkal, Gajanan; Yadav, Pragya (15 בדצמבר 2020). "Safety and immunogenicity trial of an inactivated SARS-CoV-2 vaccine-BBV152: a phase 1, double-blind, randomised control trial". medRxiv (באנגלית). doi:10.1101/2020.12.11.20210419. {{cite web}}: (עזרה)

newindianexpress.com

"Odisha fast tracks coronavirus vaccine manufacturing unit". The New Indian Express. 7 בנובמבר 2020. {{cite news}}: (עזרה)

nih.gov

pubmed.ncbi.nlm.nih.gov

"Enhancing viral vaccine production using engineered knockout vero cell lines - A second look". Vaccine. 36 (16): 2093–2103. באפריל 2018. doi:10.1016/j.vaccine.2018.03.010. PMID 29555218free {{cite journal}}: (עזרה)תחזוקה - ציטוט: postscript (link)

nytimes.com

"India's First COVID-19 Vaccine Candidate Approved for Human Trials". The New York Times. 29 ביוני 2020. {{cite news}}: (עזרה)

reuters.com

Staff, Reuters (2020-12-22). "Ocugen to co-develop Bharat Biotech's COVID-19 vaccine candidate for U.S." Reuters (באנגלית). נבדק ב-2021-01-05.

rotter.net

חברת Bharat Biotech הגישה בקשה בהודו להרשאה לשעת חירום לחיסון שלה לקורונה - חדשות רוטר, באתר Rotter.net

thehindu.com

Perappadan, Bindu Shajan (16 בדצמבר 2020). "Coronavirus | Covaxin phase-1 trial results show promising results". The Hindu (בIndian English). נבדק ב-17 בדצמבר 2020. {{cite news}}: (עזרה)
"Coronavirus | Covaxin Phase III trial from November". The Hindu (בIndian English). 23 באוקטובר 2020. {{cite news}}: (עזרה)
"Coronavirus | After SII, Bharat Biotech seeks DCGI approval for Covaxin". The Hindu (בIndian English). 7 בדצמבר 2020. {{cite news}}: (עזרה)

theprint.in

"India to develop 'fully indigenous' Covid vaccine as ICMR partners with Bharat Biotech". ThePrint. 10 במאי 2020. {{cite news}}: (עזרה)

washingtonpost.com

Press, Associated (25 ביולי 2020). "Asia Today: Amid new surge, India tests potential vaccine". Washington Post. נבדק ב-17 בדצמבר 2020. {{cite news}}: (עזרה)